fasenra
astrazeneca limited - benralizumab 30 mg/ml - solution for injection - 30 mg/ml - active: benralizumab 30 mg/ml excipient: histidine histidine hydrochloride monohydrate polysorbate 20 trehalose water for injection - fasenra is indicated as add-on therapy in patients aged 12 years and over with severe eosinophilic asthma (blood eosinophil count nlt 300 cells/µl or nlt 150 cells/µl if on oral corticosteroid treatment).
fasenra pen
astrazeneca limited - benralizumab 30 mg/ml - solution for injection - 30 mg/ml - active: benralizumab 30 mg/ml excipient: histidine histidine hydrochloride polysorbate 20 trehalose water for injection - fasenra is indicated as add-on therapy in patients aged 12 years and over with severe eosinophilic asthma (blood eosinophil count nlt 300 cells/µl or nlt 150 cells/µl if on oral corticosteroid treatment).
fasenra 30mg1ml solution for injection pre-filled syringes
astrazeneca uk ltd - benralizumab - solution for injection - 30mg/1ml
fasenra solution for injection 30mgml (autoinjector pen)
astrazeneca singapore pte ltd - benralizumab - injection, solution - benralizumab 30 mg / ml
fasenra solución inyectable
astrazeneca ab - benralizumab - benralizumab....30 mg
medicamento biotecnológico
astrazeneca ab - benralizumab - benralizumab....30 mg
fasenra 30mg/ml sol. for injection solution for injection
astrazeneca ab, sweden - benralizumab - solution for injection - 30 mg/ml
fasenra ® 30 mg
benralizumab -
fasenra solution for injection 30 mg/1 ml
مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - benralizumab 30 mg/1 ml - 30 mg/1 ml
fasenra pen solution for injection
astrazeneca ab, sweden - benralizumab - solution for injection - 30 mg/ml,